The Asia-Pacific Respiratory Monitoring Devices System Market has been estimated at USD 3.65 billion in 2020. It is projected to reach USD 6.14 billion by 2025, at a CAGR of 11% during the forecast period from 2020 to 2025. Respiratory Monitoring Devices are used individually or clinically to find the amount of air we can inhale or exhale, Saturated oxygen in the blood, or the amount of Carbon dioxide in the body.
Respiratory Diseases are rising continuously because of a decrease in air quality, urbanization, and a decrease in the number of trees. The rise in the number of smokers globally is also a cause of growing respiratory illnesses. Respiratory Monitoring Devices came into play because of the rise in respiratory diseases and high hospital costs. With Respiratory Monitoring Devices, Clinical care is shifted to home care.
Many factors are driving this market like the Prevalence of COPD, a rise in the number of Smokers, an increase in the aging population, and the Development of Advanced Technology in emerging countries. Few more factors like growing investments by key players, rise in disposable incomes are also driving the market in this region. But factors like the huge price of Monitoring Devices and increased complexity are restraining the market growth.
Asia-Pacific Respiratory Monitoring Devices Market is segmented based on Diagnostic and Monitoring Devices. Based on Diagnostic Devices, the market is segmented into spirometers and peak flow meters. The market is segmented into sleep test devices, gas analyzers, pulse oximeters, and capnograph based on Monitoring Devices. Pulse Oximeters dominate the market because of their accurate and fast results. A pulse oximeter is expected to be the top segment for the coming years, too, because of its better diagnostic results compared to others.
Geographically, this market is further segmented into India, China, Japan, Australia, and South Korea. This market is expected to rise to the top to dominate the global market in a few years. Increased interest for key players and growing opportunities are major contributors to this region’s high CAGR.
Key players in this market are Covidien GE Healthcare, Philips Healthcare, Siemens Healthcare, Resmed, Merck & Co. Inc, Calondo Pharmaceuticals Inc., Quark Pharmaceuticals Inc., Access Pharmaceuticals Inc., Sirnaomics Inc., and Traversa Therapeutics Inc.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Diagnostic and Monitoring Devices
5.1.1 Introduction
5.1.2 Spirometers
5.1.3 Sleep Test Devices
5.1.4 Gas Analyzers
5.1.5 Pulse Oximeters
5.1.6 Peak Flow Meters
5.1.7 Capnographs
5.1.8 Y-o-Y Growth Analysis, By Diagnostic and Monitoring Devices
5.1.9 Market Attractiveness Analysis, By Diagnostic and Monitoring Devices
5.1.10 Market Share Analysis, By Diagnostic and Monitoring Devices
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Diagnostic and Monitoring Devices
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Diagnostic and Monitoring Devices
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Diagnostic and Monitoring Devices
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Covidien
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 GE Healthcare
8.3 Philips Healthcare
8.4 Siemens Healthcare
8.5 Resmed
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
